Aktiesnakken — Juni 2010
-
-
bmo fyringen tror jeg ikke har noget med kapitaludvidelsen at gøre. Det kan GSK jo slet ikke bestemme
-
det er jo nok snarere sådan at LD måske står i vejen for en overtagelse af genmab
-
og derfor vil Widmer please GSK
-
ser ud til at ville starte ud i 60. Jeg synes omsætningen må være afgørende
-
jeg tror GSK vinklen vil gavne aktien rigtigt meget
-
morgen gobster
-
16
-
ja
-
59,5 nu
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind